ViroCarb Inc.

Biotechnology company developing a paradigm-shifting drug platform to stop the replication of viruses by targeting a cellular function critical for their propagation in cells. Our lead drug candidate exhibits potent broad spectrum antiviral activity against multiple viral families including SARS-CoV-2 and other members of the coronavirus family.

Team Members

Rav Mahal, PhD
Chief Business Officer